What Is Network Meta-Analysis? Methods, Assumptions, and Applications

  • Home
  • Academy
  • Meta Analysis
  • What Is Network Meta-Analysis? Methods, Assumptions, and Applications

High-Impact Journals

Interesting topics

What Is Network Meta-Analysis? Methods, Assumptions, and Applications

Network meta-analysis (NMA) is a powerful statistical method that simultaneously compares three or more healthcare interventions, even those never directly compared in trials, by combining direct evidence and indirect evidence via a common comparator. It ranks treatments, increases precision, and requires strict adherence to similarity, transitivity, and consistency assumptions.

Network meta-analysis (NMA), which is also known as multiple treatment comparison meta-analysis, is an advanced statistical technique that can be used to compare more than one treatment simultaneously. This is unlike traditional pairwise meta-analysis, which can only compare up to two treatments at a given time. This statistical technique has become very important in evidence-based medicine, health technology assessment, and clinical guideline development because it can be used to determine which treatment among many available options is the best.[1]

1. Understanding Network Meta-Analysis in Evidence Synthesis

Network meta-analysis is an extension of conventional meta-analysis, which enables the integration of results of various randomized controlled trials (RCTs) comparing the effectiveness of various treatments for the same clinical condition.

The main advantages of network meta-analysis include the following:

  • Simultaneous comparison of many treatments
  • Comparison of direct and indirect results
  • Ranking of treatments
  • Better decision-making in terms of policy development

Network meta-analyses are widely used in clinical disciplines with many treatment choices, such as oncology, cardiology, and mental health studies.[2] Researchers often refer to this approach simply as Network meta-analysis when comparing multiple treatments within a single analytical framework.

Network meta-analysis assumptions

Direct vs. Indirect Evidence

  • Direct evidence: Trials that compare A vs. B directly are considered direct evidence.
  • Indirect evidence: When trials compare A with C and B with C, it is considered indirect evidence.

By using direct and indirect evidence, it is possible to perform Network Meta-Analysis and estimate treatment effects even in the absence of direct trials.

2. Methods Used in Network Meta-Analysis

The process of carrying out network meta-analysis has various methodological stages, which are comparable to those of the systematic review process, with the difference being the additional complexity in the analysis process. The main methodological stages in network meta-analysis

  • Defining the research question with the use of the PICO model
  • Systematic literature search process
  • Study selection and data collection process
  • Creation of the network diagram
  • Statistical modelling process
  • Evaluation of the inconsistency and heterogeneity results
  • Ranking the treatments with regard to their effectiveness

Both Bayesian and frequentist models are used in the estimation of the results.[3] These analytical procedures are part of the broader framework known as Network meta-analysis methods used in advanced evidence synthesis. Common Statistical Approaches in Network Meta-Analysis include

Method Description Typical Use
Bayesian Models Use probability distributions and prior information Complex treatment networks
Frequentist Models Use traditional statistical inference Large clinical datasets
Mixed Treatment Comparison Combines direct and indirect evidence Multi-arm trials

Example :

A network meta-analysis on the treatments for hypertension could include various drug categories such as ACE inhibitors, beta blockers, calcium channel blockers, and diuretics. Although direct comparisons might be lacking between certain medications, the effectiveness of these treatments could be compared indirectly.

This statistical approach is often described as Mixed treatment comparison meta-analysis because it integrates both direct and indirect evidence across treatment networks.

3. Key Assumptions in Network Meta-Analysis

For the results of the NMA to be valid, the following assumptions must be true:

  • Transitivity: This assumption requires that the studies included in the network are comparable with respect to patient population, interventions, and outcomes.
  • Consistency: Consistency refers to the consistency between direct and indirect evidence.
  • Homogeneity: Similar to traditional meta-analysis, homogeneity should be low across studies included in each comparison.[4]
Assumption Meaning Importance
Transitivity Studies are comparable Enables indirect comparisons
Consistency Direct and indirect evidence agree Ensures reliable results
Homogeneity Study effects are similar Improves statistical validity

Research Insight

If transitivity and consistency assumptions are violated, bias is introduced into the network model. Researchers use inconsistency models and node-splitting methods to evaluate possible violations.

These principles form the core Network meta-analysis assumptions required for producing valid and reliable comparative results.

4. Applications of Network Meta-Analysis in Research

Network meta-analysis has been widely used in the context of various research studies, particularly in the field of healthcare and policy, because of its ability to enable the performance of comparative effectiveness research. Major application areas include the following:

  • Clinical treatment comparisons
  • Ranking of drug efficacy
  • Healthcare policy decisions
  • Health technology assessment
  • Development of guidelines

In many cases, researchers apply Indirect treatment comparison meta-analysis when direct head-to-head trials between treatments are unavailable. The results of network meta-analyses are being used by the Cochrane Collaboration and the NICE organization for making appropriate treatment decisions.[5] Many research teams now rely on specialized Network meta-analysis services to manage complex treatment networks and statistical modelling.

Connect with us to explore how we can support you in maintaining academic integrity and enhancing the visibility of your research across the world!

Contact Us

Conclusion

Network meta-analysis has been recognised as an important advancement in the field of evidence synthesis, which allows researchers to compare several treatments simultaneously and establish the ranking of the treatments based on the synthesised results. Network meta-analysis helps obtain a more complete picture of the effectiveness of the interventions with the aid of direct and indirect comparisons. Network meta-analysis has the potential to enhance clinical decision-making, policy development, and evidence-based medicine with the aid of rigorous methodologies and valid assumptions. Institutions conducting large evidence syntheses often use Systematic review and network meta-analysis services to ensure methodological rigor and publication-ready results.

Turn complex treatment comparisons into high-impact research. Pubrica provides end-to-end support for systematic reviews and network meta-analysis.{Get Expert Publishing Support] or [Schedule a Free Consultation]

References

  1. Salanti, G. (2012), Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res. Syn. Meth., 3: 80-97. https://doi.org/10.1002/jrsm.1037
  2. Caldwell, D. M., Ades, A. E., & Higgins, J. P. T. (2005). Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ (Clinical Research Ed.), 331(7521), 897–900. https://doi.org/10.1136/bmj.331.7521
  3. Dias, S., Sutton, A. J., Ades, A. E., & Welton, N. J. (2013). Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials: A generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Medical Decision Making: An International Journal of the Society for Medical Decision Making, 33(5), 607–617. https://doi.org/10.1177/0272989X124
  4. Riley, R.D., Lambert, P.C., Staessen, J.A., Wang, J., Gueyffier, F., Thijs, L. and Boutitie, F. (2008), Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Statist. Med., 27: 1870-1893. https://doi.org/10.1002/sim.3165
  5. Salanti, G. (2012), Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res. Syn. Meth., 3: 80-97. https://doi.org/10.1002/jrsm.1037